|
| U.S. Brand
Names |
|
| Gonak™[OTC];
Goniosol®[OTC] |

|
|
| Generic
Available |
|
|
No |

|
|
| Synonyms |
|
|
Gonioscopic Ophthalmic Solution |

|
|
| Pharmacological Index |
|
|
Ophthalmic Agent, Miscellaneous |

|
|
| Use |
|
|
Ophthalmic surgical aid in cataract extraction and intraocular implantation;
gonioscopic examinations |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Adverse
Reactions |
|
|
1% to 10%: Local irritation |

|
|
| Usual Dosage |
|
|
Introduced into anterior chamber of eye with 20-gauge or larger
cannula |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
If you experience eye pain, changes in vision, continued redness or
irritation of the eye, or if the condition worsens or persists for more than 72
hours, discontinue use and consult a physician |

|
|
| Dosage Forms |
|
|
Solution: 2.5% (15 mL) |

|
|
Copyright © 2007 Drugs Area
|